# Dulaglutide (Trulicity)

Source: https://ourhealthnetwork.com/drugs/dulaglutide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Dulaglutide?

Dulaglutide (brand name: Trulicity) is a glp-1 receptor agonist. It is prescribed to treat diabetes mellitus, type 2. Across the United States, 110,000 doctors prescribe Dulaglutide to approximately 607,000 Medicare patients.

## Brand names

Trulicity

## Indications

Dulaglutide is prescribed for the treatment of diabetes mellitus and type 2.

## Conditions treated

- [Diabetes Mellitus](https://ourhealthnetwork.com/conditions/diabetes-mellitus)
- [Type 2](https://ourhealthnetwork.com/conditions/type-2)

## Mechanism of action

TRULICITY contains dulaglutide, which is a human GLP-1 receptor agonist with 90% amino acid sequence homology to endogenous human GLP-1 (7-37). Dulaglutide activates the GLP-1 receptor, a membrane-bound cell-surface receptor coupled to adenylyl cyclase in pancreatic beta cells.

## Drug classification

- Established Pharmacologic Class: GLP-1 Receptor Agonist [EPC]
- Mechanism of Action class: Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- Route of administration: SUBCUTANEOUS

## Common side effects

abdominal pain, decreased appetite ( 6, diarrhea, nausea, vomiting

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)